- Home
- RPRX vs SQM Comparison
RPRX vs SQM Comparison
Compare RPRX & SQM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | SQM |
|---|---|---|
| Founded | 1996 | 1968 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 22.0B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RPRX | SQM |
|---|---|---|
| Price | $49.36 | $88.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $51.40 | ★ $68.80 |
| AVG Volume (30 Days) | ★ 2.5M | 1.4M |
| Earning Date | 05-06-2026 | 05-26-2026 |
| Dividend Yield | ★ 1.89% | 0.78% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.63 | N/A |
| Revenue Next Year | $4.73 | $7.83 |
| P/E Ratio | ★ $27.85 | $39.64 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $31.97 | $29.36 |
| 52 Week High | $50.08 | $95.46 |
Technical Indicators
Market Signals| Indicator | RPRX | SQM |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 57.85 |
| Support Level | $35.34 | $68.06 |
| Resistance Level | N/A | $95.46 |
| Average True Range (ATR) | 0.88 | 3.73 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 77.82 | 59.56 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.